Algeta
A company focused on developing, manufacturing, and marketing novel targeted therapies for patients with cancer.
Launch date
Employees
Company register number 927866153
Oslo Norway (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | €23.0m | Series A | |
| N/A | N/A | IPO | |
$35.0m | Growth Equity VC | ||
| N/A | $45.0m | Growth Equity VC | |
N/A | Acquisition | ||
| Total Funding | €95.7m | ||
Related Content
Recent News about Algeta
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.